The Rapid Shallow Breathing Index (RSBI) is a Widely Used Predictor for Weaning Patients From Mechanical Ventilation This Study Aims to Determine the Predictive Value of RSBI Measurements for Extubation Success in Mechanically Ventilated ICU Patients
Rapid Shallow Index as Successfully Predictor of Outcome of Extubating
1 other identifier
observational
70
1 country
1
Brief Summary
Early extubation in ICU patients is crucial for reducing complications of prolonged ventilation, including morbidity and mortality. The Rapid Shallow Breathing Index (RSBI) is a widely used predictor for weaning patients from mechanical ventilation. This study aims to determine the predictive value of RSBI measurements for extubation success in mechanically ventilated ICU patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 9, 2026
CompletedFirst Posted
Study publicly available on registry
March 12, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
March 13, 2026
March 1, 2026
6 months
March 9, 2026
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Extubation success (no reintubation/adjuvant support within 48h).
no reintubation or adjuvant oxygen therapy
48 hour
Eligibility Criteria
mechnically ventilated patient eligable for extubation
You may qualify if:
- Adults \> 22 years.
- Mechanically ventilated patients meeting extubation readiness:
- FiO₂ ≤ 0.4, PEEP ≤ 8 cmH₂O, PaO₂/FiO₂ ≥ 200 mmHg.
- Respiratory rate ≤ 35 breaths/min, pH \> 7.30.
- Hemodynamic stability (HR ≤ 120 bpm, SBP 90-160 mmHg).
- Glasgow Coma Scale \>10, adequate cough reflex.
- Includes postoperative, elective/emergency reintubation, and tracheostomized patients.
You may not qualify if:
- Age \<22 years.
- Refusal of informed consent.
- Altered mental status (e.g., traumatic brain injury).
- Hemodynamic instability or deep sedation (RASS ≤ -2).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams Hospital
Cairo, Abbasia, 1181, Egypt
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia,icu and pain management
Study Record Dates
First Submitted
March 9, 2026
First Posted
March 12, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share